«Antibiotic Stewardship» programmes & antibiotic resistance
|
|
- Barry Shields
- 6 years ago
- Views:
Transcription
1 «Antibiotic Stewardship» programmes & antibiotic resistance Winfried V. Kern Abteilung Infektiologie Universitätsklinikum Freiburg
2 Agenda Definition Healthcare quality & patient safety aspects Research aspects
3 What is Antibiotic Stewardship? ongoing effort by a healthcare institution to optimize antimicrobial use among hospitalized patients to... - improve patient outcomes - ensure cost-effective therapy, and - reduce adverse sequelae of antimicrobial use (including antimicrobial resistance). MacDougall & Polk CMR 2005
4 What is Antibiotic Stewardship? system ongoing effort by a healthcare institution to optimize antimicrobial use among hospitalized patients to... - improve patient outcomes - ensure cost-effective therapy, and - reduce adverse sequelae of antimicrobial use (including antimicrobial resistance). MacDougall & Polk CMR 2005
5 The development of new antibiotics without having mechanisms to ensure their appropriate use is much like supplying your alcoholic patients with a finer brandy. Dennis Maki 1998
6
7 assumptions prescribing is (often) suboptimal
8 assumptions prescribing is (often) suboptimal (and often too excessive)
9 assumptions prescribing is (often) suboptimal (and often too excessive) and induces resistance
10 assumptions prescribing is (often) suboptimal (and often too excessive) and reduces resistance optimized (and/or reduced) prescribing improves outcomes and can minimize or even reverse antimicrobial resistance
11 Bratzler et al Arch Surg 2005
12 European data (ESAC-PPS 2006*) *20 hospitals, 11,571 patients, 30% with antibiotics Ansari et al CID 2009
13 European data (ESAC-PPS 2008*) *50 hospitals, 28 countries ESAC investigators 2011
14 European data (ESAC-PPS 2010*) surgical prophylaxis exceeded one day in 61% of cases *66 hospitals, 23 countries Zarb et al Eurosurv 2012
15 Burden of hospital-wide inadequate antibiotic prescriptions 9% n=776 Turkey % n=107 France % n=104 France % n=1079 UK % n=2306 Israel % n=539 Switzerland % n=166 Spain % n=493 Croatia, %, n=1270 Switzerland % n=129 USA % n=177 Italy % n=105 France % n=281 Turkey % n=938 Netherlands % n=189 Spain % n=378 Turkey % n=223 Turkey % n=173 Switzerland % n=156 Turkey % n=438 Croatia % n=122 France 2007
16 assumptions prescribing is (often) suboptimal (and often too excessive) and induces resistance
17 60 50 Taiwan Spain % Penicillin-nichtempfindliche Pneumokokken This is where a large graphic or chart can go. 10 Greece 20 USA Portugal Ireland Canada Luxemburg Iceland Austria Italy UK Belgium Australia Germany Sweden Finland Denmark Netherlands Norway 30 France 40 Antibiotikaverbrauch (definierte Tagesdosen [DDD]/1000 Tage) Albrich et al. Emerg Infect Dis 2004
18
19 Group-level data Group-level data Imipenem DDD per 1000 pt days % 95% 90% 85% 80% 75% 70% Clin Infect Dis 2001; 33: Gram-negative bacilli Percent imipenem-susceptible
20 Individual-level data Probability of resistance Adjusted hazard ratio: 5.7 (95% CI, ) No imipenem Days in hospital Imipenem Clin Infect Dis 2001; 33:
21 Limitations to consider the limited evidence provided by purely observational (vs interventional studies) individual-level or group-level analysis (ecological bias)
22 7 FQR-EC and FQ Use E. coli (r = 0.79; p = 0.002) % FQ Resistance DDD/1000 patient-days Lautenbach, SHEA, 2002
23 FQR-EC and the Dow Jones Index E. coli (r=.96; p<.001) % FQ Resistance DJIA Courtesy: Y. Carmeli
24 assumptions prescribing is (often) suboptimal (and often too excessive) and reduces resistance optimized (and/or reduced) prescribing improves outcomes and can minimize or even reverse antimicrobial resistance
25 Interventions Endpoint: prescribing quality local guidelines, audit/education with feedback improvement in antimicrobial prescription included among the annual objectives linked to economic incentives in every department CMI 2013
26 Cisneros et al CMI 2013
27 Cisneros et al CMI 2013
28 Cisneros et al CMI 2013
29 Cisneros et al CMI 2013
30 Limitations consider endpoints prescribing density prescribing quality cost (from which perspective) patient outcomes vs microbial endpoints)
31
32
33
34
35
36 Drug resistance in E. coli without apparent selection pressure Bean et al. JAC 2005
37 Limitations to consider design of interventional studies experimental (e.g. cluster-randomized) vs quasiexperimental (e.g. controlled before/after) analysis (e.g. time-series analysis, adverse events)
38 10 Intervention to Reduce Use of Alert Antibiotics 8 DDD/100 bed-days Months Change: DDD/100 P t test Slope <0.001 Ansari et al JAC 2003 Courtesy: Peter Davey, Dundee (UK)
39 Baseline Intervention Postintervention Kim et al JAC 2008
40 Limitations sustainability often not described which component is the most critical? (and needs most investment)
41 Limitations background epidemiology may be different confounding: cultural environment & prevalent prescribing etiquette risk for limited transferability/generalizability?? be aware of potentially adverse effects!!
42 assumptions & strategies what is optimized and/or reduced? no use by indication shorter treatment PK/PD-optimized treatment (dosing) use (or switch to) the ecologically ( collateral damage ) best-performing drugs
43 e.g. Bronchitis
44
45
46 e.g. Uncomplicated UTI
47 double-blind trial n=253 women (18-70 years old) diclofenac vs norfloxacin for 3 days (with fosfomycin 3 g as rescue treatment) resolution of symptoms (day 3): 50% vs 77% (risk difference 27%, 95%CI 15-38%) 61% of patients in the diclofenac group ever consumed antibiotics
48 double-blind trial n=253 women (18-70 years old) diclofenac vs norfloxacin for 3 days (with fosfomycin 3 g as rescue treatment) resolution of symptoms (day 3): 50% vs 77% (risk difference 27%, 95%CI 15-38%) 61% of patients in the diclofenac group ever consumed antibiotics
49 assumptions & strategies what is optimized and/or reduced? no use by indication shorter treatment PK/PD-optimized treatment (dosing) use (or switch to) the ecologically ( collateral damage ) best-performing drugs
50 assumptions & strategies what is optimized and/or reduced? no use by indication shorter treatment PK/PD-optimized treatment (dosing) use (or switch to) the ecologically ( collateral damage ) best-performing drugs
51 Macrolide resistance among oral streptococci Malhotra-Kumar et al. Lancet 2007; 369:
52 Makrolide verändern nachhaltig die Mundhöhlenflora Amoxicillin auch?? Plazebokontrollierte Studie mit Amoxicillin (3x1g, n=37) oder Plazebo (n=38) über 1 Woche Rachenspülungen untersucht bis Tag 28 auf Streptokokken mit verminderter Empfindlichkeit auf Penicillin und Amoxicillin Ergebnisse: Malhotra-Kumar et al; K-1579
53 assumptions & strategies what is optimized and/or reduced? no use by indication shorter treatment PK/PD-optimized treatment (dosing) use (or switch to) the ecologically ( collateral damage ) best-performing drugs
54 Fluoroquinolone studies Some milestone studies, e.g. the 3F (French Fluoroquinolone Free-Study): multicenter trial showing substantial MRSA reduction following a 90% fluoroquinolone reduction (Charbonneau et al CID 2006) (!!)
55 Ceph + Fluorquinolone studies Recently many more 3C and 3C+ studies 3C: Ceph + Cipro/other FQs = C. difficile 3C+: Ceph + Cipro/other FQs = C. difficile ± ESBL ± MRSA
56 Talpaert et al JAC 2011
57 Talpaert et al JAC 2011
58 Talpaert et al JAC 2011
59 [109] Dancer et al IJAA 2013
60 Summary Stewardship is important but complex Best evidence so far regarding impact on C.difficile infection Very limited evidence for impact on MDR gram-negatives Many more interventional studies (hospital and outpatient setting) are needed
61
Consumption of antibiotics in hospitals. Antimicrobial stewardship.
Consumption of antibiotics in hospitals. Antimicrobial stewardship. Inge C. Gyssens MD PhD Radboud university medical center, Nijmegen, The Netherlands Hasselt University, Belgium 1. Antibiotic use in
More informationSummary of the latest data on antibiotic consumption in the European Union
Summary of the latest data on antibiotic consumption in the European Union ESAC-Net surveillance data November 2016 Provision of reliable and comparable national antimicrobial consumption data is a prerequisite
More informationOECD WORK ON AMR: TACKLING THE NEGATIVE CONSEQUENCES OF ANTIBIOTIC RESISTANCE ON HUMAN HEALTH. Michele Cecchini OECD Health Division
OECD WORK ON AMR: TACKLING THE NEGATIVE CONSEQUENCES OF ANTIBIOTIC RESISTANCE ON HUMAN HEALTH Michele Cecchini OECD Health Division Antimicrobial Resistance is a Global Threat Modern medicine and surgery
More informationQuelle politique antibiotique pour l Europe? Dominique L. Monnet
Quelle politique antibiotique pour l Europe? Dominique L. Monnet National Center for Antimicrobials & Infection Control Statens Serum Institut, Copenhagen, Denmark Opinion of the Section for Protection
More informationSummary of the latest data on antibiotic consumption in the European Union
Summary of the latest data on antibiotic consumption in the European Union November 2012 Highlights on antibiotic consumption Antibiotic use is one of the main factors responsible for the development and
More informationAntibiotic resistance: the rise of the superbugs
Antibiotic resistance: the rise of the superbugs Allen Cheng Associate Professor of Infectious Diseases Epidemiology, Alfred Health; Monash University About me Specialist in infectious diseases Head, Infection
More informationThe challenge of growing resistance
EXECUTIVE SUMMARY Around 2.4 million people could die in Europe, North America and Australia between 2015-2050 due to superbug infections unless more is done to stem antibiotic resistance. However, three
More informationrates adjusted for age, sex, infection subclass, and type of antibiotic treatment used) by British Medical Journal Publishing Group
Antibiotic treatment failure in four common infections in UK primary care 1991-2012: longitudinal analysis Craig J Currie BMJ 2014;349:g5493 23 September 2014 More than one in 10 initial antibiotic monotherapies
More informationProf. Otto Cars. We are overconsuming a global resource. It is a collective responsibility by governments, supranational organisatons
What are the consequences of rising antibiotic resistance for Sweden? Prof. Otto Cars Chairman The Swedish Strategic programme against antibiotic resistance (Strama) We are overconsuming a global resource
More informationWhat is the problem? Latest data on antibiotic resistance
European Antibiotic Awareness Day 2009 What is the problem? Latest data on antibiotic resistance Zsuzsanna Jakab, ECDC Director Launch Seminar for EAAD Stockholm, 18 November 2009 Fluoroquinolone-resistant
More informationInitiatives taken to reduce antimicrobial resistance in DK and in the EU in the health care sector
Initiatives taken to reduce antimicrobial resistance in DK and in the EU in the health care sector Niels Frimodt-Møller Professor, MD DMSc Dept. of Clinical Microbiology Hvidovre Hospital, Copenhagen,
More informationAntimicrobial consumption
Antimicrobial consumption Annual Epidemiological Report for 2017 Key facts Twenty-seven countries, comprising 25 EU Member States and two EEA countries (Iceland and Norway) reported data on antimicrobial
More informationWHO global and regional activities on AMR and collaboration with partner organisations
WHO global and regional activities on AMR and collaboration with partner organisations Dr Danilo Lo Fo Wong Programme Manager for Control of Antimicrobial Resistance Building the AMR momentum 2011 WHO/Europe
More informationStop overuse of antibiotics in humans rational use
Stop overuse of antibiotics in humans rational use Dominique L. Monnet, Senior Expert and Head of Disease Programme Antimicrobial resistance and Healthcare-associated infections (ARHAI) European Centre
More informationEuropean poultry industry trends
European poultry industry trends November 5 th 2014, County Monaghan Dr. Aline Veauthier & Prof. Dr. H.-W. Windhorst (WING, University of Vechta) 1 Agenda The European Chicken Meat Market - The global
More informationAntimicrobial resistance (EARS-Net)
SURVEILLANCE REPORT Annual Epidemiological Report for 2014 Antimicrobial resistance (EARS-Net) Key facts Over the last four years (2011 to 2014), the percentages of Klebsiella pneumoniae resistant to fluoroquinolones,
More informationAMR epidemiological situation: ECDC update
One Health Network on Antimicrobial Resistance (AMR) AMR epidemiological situation: ECDC update Dominique L. Monnet, on behalf of ECDC Antimicrobial Resistance and Healthcare-Associated Infections (ARHAI)
More informationQuality indicators and outcomes in the devolved nations Scotland
Quality indicators and outcomes in the devolved nations Scotland Dr Jacqueline Sneddon, MRPharmS Project Lead, Scottish Antimicrobial Prescribing Group Federation of Infection Societies Conference Birmingham,
More informationA web-based interactive tool to explore antibiotic resistance and consumption via maps and charts
http://resistancemap.cddep.org A web-based interactive tool to explore antibiotic resistance and consumption via maps and charts CDDEP first developed ResistanceMap in 21. The new ResistanceMap now includes
More informationThe evolutionary epidemiology of antibiotic resistance evolution
The evolutionary epidemiology of antibiotic resistance evolution François Blanquart, CNRS Stochastic Models for the Inference of Life Evolution CIRB Collège de France Quantitative Evolutionary Microbiology
More informationHealth Service Executive Parkgate St. Business Centre, Dublin 8 Tel:
Health Service Executive Parkgate St. Business Centre, Dublin 8 Tel: 01 635 2500 www.hse.ie Health Service Executive Oak House, Millennium Park, Naas, Co. Kildare Tel: 045 880 400 www.hse.ie The prevention
More informationExecutive Summary: A Point Prevalence Survey of Antimicrobial Use: Benchmarking and Patterns of Use to Support Antimicrobial Stewardship Efforts
Executive Summary: A Point Prevalence Survey of Antimicrobial Use: Benchmarking and Patterns of Use to Support Antimicrobial Stewardship Efforts Investigational Team: Diane Brideau-Laughlin BSc(Pharm),
More informationAntimicrobial Stewardship Esperienza Torinese
Pisa 15 Novembre 2016 Antimicrobial Stewardship Esperienza Torinese Francesco G. De Rosa Dipartimento di Scienze Mediche Università di Torino Antimicrobial Stewardship First introduced by Dale Gerding
More informationStratégie et action européennes
Résistance aux antibiotiques : une impasse thérapeutique? Implications nationales et internationales Stratégie et action européennes Dominique L. Monnet, Senior Expert and Head of Disease Programme Antimicrobial
More informationResponsible use of antibiotics
Responsible use of antibiotics Uga Dumpis MD, PhD Department of Infectious Diseases and Infection Control Pauls Stradiņs Clinical University Hospital Challenges in the hospitals Antibiotics are still effective
More informationBest Practices: Goals of Antimicrobial Stewardship
Best Practices: Goals of Antimicrobial Stewardship Gail Scully, M.D, M.P.H. and Elizabeth Radigan, PharmD, BCPS UMass Memorial Medical Center Division of Infectious Disease Department of Medicine September
More informationViResiST: its contribution to our knowledge of the relationship between antimicrobial use and resistance. Dominique L. Monnet
ViResiST: its contribution to our knowledge of the relationship between antimicrobial use and resistance Dominique L. Monnet About antibiotics... As soon as we use it, we loose it The more we use it, the
More informationHosted by the Infection Prevention Society A Webber Training Teleclass
Broadcast Live From the Annual Conference of the Infection Prevention Society www.ips.uk.net The only drugs that are: Gary French Guy s & St Thomas Hospital & King s College, London Not directed against
More informationThe International Collaborative Conference in Clinical Microbiology & Infectious Diseases
The International Collaborative Conference in Clinical Microbiology & Infectious Diseases PLUS: Antimicrobial stewardship in hospitals: Improving outcomes through better education and implementation of
More informationAntimicrobial Stewardship
Antimicrobial Stewardship Report: 11 th August 2016 Issue: As part of ensuring compliance with the National Safety and Quality Health Service Standards (NSQHS), Yea & District Memorial Hospital is required
More informationSCIENTIFIC REPORT. Analysis of the baseline survey on the prevalence of Salmonella in turkey flocks, in the EU,
The EFSA Journal / EFSA Scientific Report (28) 198, 1-224 SCIENTIFIC REPORT Analysis of the baseline survey on the prevalence of Salmonella in turkey flocks, in the EU, 26-27 Part B: factors related to
More informationDr. Torsten Hoppe-Tichy, Chief Pharmacist. How to implement Antibiotic Stewardship without having the resources for that?
Dr. Torsten Hoppe-Tichy, Chief Pharmacist How to implement Antibiotic Stewardship without having the resources for that? No conflict of interests Questions to the audience (Yes/No) - Is it promising to
More informationDr Eleri Davies. Consultant Microbiologist and Infection Control Doctor, Public Health Wales NHS Trust
Dr Eleri Davies Consultant Microbiologist and Infection Control Doctor, Public Health Wales NHS Trust Antimicrobial stewardship What is it? Why is it important? Treatment and management of catheter-associated
More informationMDRO s, Stewardship and Beyond. Linda R. Greene RN, MPS, CIC
MDRO s, Stewardship and Beyond Linda R. Greene RN, MPS, CIC linda_greene@urmc.rochester.edu Evolving Threat of Antimicrobial Resistance Why are MDROs important? Limited treatment options Associated with:
More informationRESISTANCE, USE, INTERVENTIONS. Hugh Webb
RESISTANCE, USE, INTERVENTIONS Hugh Webb EU Initiatives: EARSS and ESAC. Antimicrobial Use and Resistance The Relationship. Bias and confounding in published studies. Mathematical modelling of resistance
More informationWHO laboratory-based global survey on multidrug-resistant organisms (MDROs) in health care interim analysis
WHO laboratory-based global survey on multidrug-resistant organisms (MDROs) in health care interim analysis Aim: to estimate the burden of MDROs isolated among inpatients in a wide range of health-care
More informationKonsequenzen für Bevölkerung und Gesundheitssysteme. Stephan Harbarth Infection Control Program
Konsequenzen für Bevölkerung und Gesundheitssysteme Stephan Harbarth Infection Control Program University of Geneva Hospitals Outline Introduction What data sources are available? AMR-associated outcomes
More informationOptimizing Antimicrobial Stewardship Activities Based on Institutional Resources
Optimizing Antimicrobial Stewardship Activities Based on Institutional Resources Andrew Hunter, PharmD, BCPS Infectious Diseases Clinical Pharmacy Specialist Michael E. DeBakey VA Medical Center Andrew.hunter@va.gov
More informationAntimicrobial Resistance Prevention (Action Package: Prevent-1) Putting AMR on the priority list: Sweden Dr. Nils Anders Tegnell, Director, The
Antimicrobial Resistance Prevention (Action Package: Prevent-1) Putting AMR on the priority list: Sweden Dr Nils Anders Tegnell, Director, The Public Health Agency of Sweden The Global Challenge Antibiotics
More informationMAGNITUDE OF ANTIMICROBIAL USE. Antimicrobial Stewardship in Acute and Long Term Healthcare Facilities: Design, Implementation and Challenges
Antimicrobial Stewardship in Acute and Long Term Healthcare Facilities: Design, Implementation and Challenges John A. Jernigan, MD, MS Division of Healthcare Quality Promotion Centers for Disease Control
More informationStewardship tools. Dilip Nathwani Ninewells Hospital and Medical School Dundee, UK
Stewardship tools Dilip Nathwani Ninewells Hospital and Medical School Dundee, UK What is Antimicrobial Stewardship (AMS)? Antimicrobial stewardship has been defined as the optimal selection, dosage, and
More informationMRSA in the United Kingdom status quo and future developments
MRSA in the United Kingdom status quo and future developments Dietrich Mack Chair of Medical Microbiology and Infectious Diseases The School of Medicine - University of Wales Swansea P R I F Y S G O L
More informationAntimicrobial Cycling. Donald E Low University of Toronto
Antimicrobial Cycling Donald E Low University of Toronto Bad Bugs, No Drugs 1 The Antimicrobial Availability Task Force of the IDSA 1 identified as particularly problematic pathogens A. baumannii and
More informationAntibiotic Stewardship in the Hospital Setting
Antibiotic Stewardship in the Hospital Setting G. Evans, MD FRCPC Medical Director, Infection Prevention & Control Kingston General Hospital & Hotel Dieu Hospital EOPIC September 26, 2012 Stewardship stew-ard-ship
More informationEFSA s activities on Antimicrobial resistance in the food chain. Dr. Ernesto Liebana Head of BIOCONTAM Unit. EFSA
EFSA s activities on Antimicrobial resistance in the food chain Dr. Ernesto Liebana Head of BIOCONTAM Unit. EFSA EFSA IS The reference body for risk assessment of food and feed in the European Union. Its
More informationSaving Posts by Making Markets
Saving Posts by Making Markets Marshall Van Alstyne Boston University & MIT Twitter: @InfoEcon mva@bu.edu, marshall@mit.edu Postal Vision 2020 Washington, DC April 11, 2014 2013 Van Alstyne et. al. 2014
More informationWhat s happening across the UK with antimicrobial prescribing quality indicators?
What s happening across the UK with antimicrobial prescribing quality indicators? Dr Jacqueline Sneddon, MRPharmS Project Lead, Scottish Antimicrobial Prescribing Group Antimicrobial Management Team Network
More informationHSE - Health Protection Surveillance Centre Surveillance of Antimicrobial Consumption in Ireland
Surveillance of Antimicrobial Consumption in Ireland Ajay Oza A European Study on the Relationship between Antimicrobial Use and Antimicrobial Resistance (1998-1999) Bronzwaer et al 2002 Emerging Infectious
More informationAntibiotic courses and antibiotic conservation, getting the balance right
Antibiotic courses and antibiotic conservation, getting the balance right Prof Martin Llewelyn Brighton and Sussex Medical School Brighton and Sussex University Hospitals NHS Trust The King's Fund: Ideas
More informationEU Health Priorities. Jurate Svarcaite Secretary General PGEU
EU Health Priorities Jurate Svarcaite Secretary General PGEU Members: Professional Bodies & Pharmacists Associations 2016: 33 Countries Austria Belgium Bulgaria Croatia Cyprus Czech Rep Denmark Estonia
More informationHow do people obtain antibiotics in European countries: an overview
How do people obtain antibiotics in European countries: an overview Dominique L. Monnet, Programme Coordinator Senior Expert, Scientific Advice Unit & the National Antimicrobial Resistance Focal Points
More informationAntimicrobial Resistance Update for Community Health Services
Antimicrobial Resistance Update for Community Health Services Elizabeth Beech Healthcare Acquired Infection and Antimicrobial Resistance Project Lead NHS England October 2015 elizabeth.beech@nhs.net Superbugs
More informationANTIMICROBIAL STEWARDSHIP
ANTIMICROBIAL STEWARDSHIP Australian Pig Veterinarians Annual Conference 11-12 September, 2017 Stephen Page Advanced Veterinary Therapeutics swp@advet.com.au OUTLINE Importance of AMR Antimicrobial use
More informationAntibiotic treatment in the ICU 1. ICU Fellowship Training Radboudumc
Antibiotic treatment in the ICU 1 ICU Fellowship Training Radboudumc Main issues Delayed identification of microorganisms Impact of critical illness on Pk/Pd High prevalence of antibiotic resistant strains
More informationPractical application of antibiotic use data. Uga Dumpis MD PhD Pauls Stradins Clinical University Hospital University of Latvia
Practical application of antibiotic use data Uga Dumpis MD PhD Pauls Stradins Clinical University Hospital University of Latvia No conflict of interest Questions for the ACASEM Survey Question 1. Antimicrobial
More informationUPDATE ON ANTIMICROBIAL STEWARDSHIP REGULATIONS AND IMPLEMENTATION OF AN AMS PROGRAM
UPDATE ON ANTIMICROBIAL STEWARDSHIP REGULATIONS AND IMPLEMENTATION OF AN AMS PROGRAM Diane Rhee, Pharm.D. Associate Professor of Pharmacy Practice Roseman University of Health Sciences Chair, Valley Health
More informationChart showing the average height of males and females in various world countries.
Chart showing the average height of males and females in various world countries. Country/Region Average male height Average female height Sampled Age Range Albania 174.0 cm (5 ft 8 1/2 in) 161.8 cm (5
More informationPneumococcus: Antibiotic Resistance in the Region
Pneumococcus: Antibiotic Resistance in the Region Çiğdem Bal Kayacan Istanbul University Istanbul Faculty of Medicine Department of Microbiology & Clinical Microbiology Drug Resistance in S.pneumoniae
More informationLindsay E. Nicolle, MD, FRCPC Professor, Internal Medicine & Medical Microbiology University of Manitoba Canada
Lindsay E. Nicolle, MD, FRCPC Professor, Internal Medicine & Medical Microbiology University of Manitoba Canada Antimicrobial Stewardship ICHE 2012; 33 Coordinated interventions designed to improve and
More informationObjective 1/20/2016. Expanding Antimicrobial Stewardship into the Outpatient Setting. Disclosure Statement of Financial Interest
Expanding Antimicrobial Stewardship into the Outpatient Setting Michael E. Klepser, Pharm.D., FCCP Professor Pharmacy Practice Ferris State University College of Pharmacy Disclosure Statement of Financial
More informationAntimicrobial Stewardship in Scotland
Antimicrobial Stewardship in Scotland UKCPA/FIS Scientific Meeting 18 th November 2010 Triumphs and Unintended Consequences Dr Jacqueline Sneddon Project Lead for Scottish Antimicrobial Prescribing Group
More informationThe threat of multidrug-resistant microorganisms and how to deal with it in Europe
The threat of multidrug-resistant microorganisms and how to deal with it in Europe Dominique L. Monnet, Senior Expert and Head of Disease Programme Antimicrobial resistance and Healthcare-associated infections
More informationECDC activities on antimicrobial resistance & healthcare-associated infections (ARHAI Programme) Ülla-Karin Nurm, ECDC Tallinn, 13 May 2013
ECDC activities on antimicrobial resistance & healthcare-associated infections (ARHAI Programme) Ülla-Karin Nurm, ECDC Tallinn, 13 May 2013 What is the European Union? 27 Member States 24 official languages
More informationAntimicrobial Stewardship Northern Ireland
Antimicrobial Stewardship Northern Ireland Dr Lorraine Doherty Assistant Director of Public Health (Health Protection) Public Health Agency 15 November 2011 Co Authors Dr Muhammad Sartaj. SpR Public Health
More informationANTIBIOTIC STEWARDSHIP
ANTIBIOTIC STEWARDSHIP Adrie Bekker - Kenya 2018 Department of Pediatric and Child Health, Division of Neonatology University of Stellenbosch, Tygerberg Hospital DEFINITION OF ANTIMICROBIAL STEWARDSHIP
More information11/22/2016. Antimicrobial Stewardship Update Disclosures. Outline. No conflicts of interest to disclose
Antimicrobial Stewardship Update 2016 APIC-CI Conference November 17 th, 2016 Jay R. McDonald, MD Chief, ID Section VA St. Louis Health Care System Assistant Professor of medicine Washington University
More informationAdvances in Antimicrobial Stewardship (AMS) at University Hospital Southampton
Advances in Antimicrobial Stewardship (AMS) at University Hospital Southampton Dr Julian Sutton Consultant in Infectious Diseases & Medical Microbiology Federation of Infection Societies 1 st December,
More informationIDENTIFICATION: PROCESS: Waging the War against C. difficile Radical Multidisciplinary Approaches From a Community Hospital
Waging the War against C. difficile Radical Multidisciplinary Approaches From a Community Hospital Organization Name: St. Joseph Medical Center Type: Acute Care Hospital Contact Person: Leigh Chapman RN,
More informationHow to get senior hospital and clinical engagement
How to get senior hospital and clinical engagement Professor Alison Holmes Professor of Infectious Diseases Director, NIHR Health Protection Research Unit: HCAI and AMR Engagement through Organisational
More informationAntimicrobial Update. Alison MacDonald Area Antimicrobial Pharmacist NHS Highland April 2018
Antimicrobial Update Alison MacDonald Area Antimicrobial Pharmacist NHS Highland alisonc.macdonald@nhs.net April 2018 Starter Questions Setting the scene... What if antibiotics were no longer effective?
More informationMRSA control strategies in Europekeeping up with epidemiology?
MRSA 15 years in Belgium MRSA control strategies in Europekeeping up with epidemiology? Marc J. Struelens, MD, PhD Senior Expert, Scientific Advice Unit European Centre for Disease Prevention and Control,
More information9/30/2016. Dr. Janell Mayer, Pharm.D., CGP, BCPS Dr. Lindsey Votaw, Pharm.D., CGP, BCPS
Dr. Janell Mayer, Pharm.D., CGP, BCPS Dr. Lindsey Votaw, Pharm.D., CGP, BCPS 1 2 Untoward Effects of Antibiotics Antibiotic resistance Adverse drug events (ADEs) Hypersensitivity/allergy Drug side effects
More informationAntimicrobial Resistance. Tackling the Burden in the European Union. Briefing note for EU/EEA countries
Antimicrobial Resistance Tackling the Burden in the European Union Briefing note for EU/EEA countries Antimicrobial Resistance Tackling the Burden in the European Union Contents Key messages 03 Use of
More informationEuropean Medicines Agency role and experience on antimicrobial resistance
European Medicines Agency role and experience on antimicrobial resistance Regional Training Workshop on Antimicrobial Resistance (AMR) Responding to the global challenge of AMR threats: toward a one health
More informationAntimicrobial consumption and resistance in humans in the EU and conclusions from the ECDC-EFSA- EMA JIACRA report
Antimicrobial consumption and resistance in humans in the EU and conclusions from the ECDC-EFSA- EMA JIACRA report Dominique L. Monnet, on behalf of ECDC Antimicrobial Resistance and Healthcare-Associated
More informationCore Elements of Antibiotic Stewardship for Nursing Homes
Core Elements of Antibiotic Stewardship for Nursing Homes Nimalie D. Stone, MD, MS Medical Epidemiologist for LTC Division of Healthcare Quality Promotion Centers for Disease Control and Prevention Antimicrobial
More informationPrevention and control of antimicrobial resistance in healthcare settings: raising awareness about best practices
Prevention and control of antimicrobial resistance in healthcare settings: raising awareness about best practices Dominique L. Monnet, on behalf of ECDC Antimicrobial Resistance and Healthcare-Associated
More informationAntibiotic Stewardship in Nursing Homes SAM GUREVITZ PHARM D, CGP ASSOCIATE PROFESSOR BUTLER UNIVERSITY COLLEGE OF PHARMACY AND HEALTH SCIENCE
Antibiotic Stewardship in Nursing Homes SAM GUREVITZ PHARM D, CGP ASSOCIATE PROFESSOR BUTLER UNIVERSITY COLLEGE OF PHARMACY AND HEALTH SCIENCE Crisis: Antibiotic Resistance Success Strategy WWW.optimistic-care.org
More informationAntimicrobial consumption
SURVEILLANCE REPORT Annual Epidemiological Report for 2016 Antimicrobial consumption Key facts Twenty-nine countries, including 27 EU Member States and two EEA countries (Iceland and Norway) reported data
More informationJump Starting Antimicrobial Stewardship
Jump Starting Antimicrobial Stewardship Amanda C. Hansen, PharmD Pharmacy Operations Manager Carilion Roanoke Memorial Hospital Roanoke, Virginia March 16, 2011 Objectives Discuss guidelines for developing
More informationGUIDE TO INFECTION CONTROL IN THE HOSPITAL. Antibiotic Resistance
GUIDE TO INFECTION CONTROL IN THE HOSPITAL CHAPTER 4: Antibiotic Resistance Author M.P. Stevens, MD, MPH S. Mehtar, MD R.P. Wenzel, MD, MSc Chapter Editor Michelle Doll, MD, MPH Topic Outline Key Issues
More informationOptimize Durations of Antimicrobial Therapy
Optimize Durations of Antimicrobial Therapy Evidence & Application Jill Cowper, Pharm.D. Division Infectious Diseases Pharmacist Parallon Supply Chain Solutions Richmond, VA P: 607 221 5101 jill.butterfield@parallon.com
More informationAntimicrobial stewardship
Antimicrobial stewardship Magali Dodemont, Pharm. with the support of Wallonie-Bruxelles International WHY IMPLEMENT ANTIMICROBIAL STEWARDSHIP IN HOSPITALS? Optimization of antimicrobial use To limit the
More informationHospital ID: 831. Bourguiba Hospital. Tertiary hospital
Global Point Prevalence Survey of Antimicrobial Consumption and Resistance in hospitals worldwide Hospital ID: 831 Habib Bourguiba Hospital Tertiary hospital Tunisia Point Prevalence Survey Habib 2017
More informationRecommendations for Implementation of Antimicrobial Stewardship Restrictive Interventions in Acute Hospitals in Ireland
Recommendations for Implementation of Antimicrobial Stewardship Restrictive Interventions in Acute Hospitals in Ireland A report by the Hospital Antimicrobial Stewardship Working Group, a subgroup of the
More informationby author ESCMID Online Lecture Library EUCAST The European Committee on Antimicrobial Susceptibility Testing September 2010
EUCAST The European Committee on Antimicrobial Susceptibility Testing September 2010 Gunnar Kahlmeter Chairman of EUCAST Terms and acronyms AST Antimicrobial Susceptibility Testing MIC Minimum Inhibitory
More informationASCENSION TEXAS Antimicrobial Stewardship: Practical Implementation Strategies
ASCENSION TEXAS Antimicrobial Stewardship: Practical Implementation Strategies Theresa Jaso, PharmD, BCPS (AQ-ID) Network Clinical Pharmacy Specialist Infectious Diseases Seton Healthcare Family Ascension
More informationEuropean Antibiotic Awareness Day: Promoting prudent antibiotic use in Europe
European Antibiotic Awareness Day: Promoting prudent antibiotic use in Europe Dominique L. Monnet, Head of Disease Programme, Antimicrobial Resistance and Healthcare-Associated Infections (ARHAI) Joint
More informationInappropriate Use of Antibiotics and Clostridium difficile Infection. Jocelyn Srigley, MD, FRCPC November 1, 2012
Inappropriate Use of Antibiotics and Clostridium difficile Infection Jocelyn Srigley, MD, FRCPC November 1, 2012 Financial Disclosures } No conflicts of interest } The study was supported by a Hamilton
More informationEFSA s activities on Antimicrobial Resistance
EFSA s activities on Antimicrobial Resistance CRL-AR, Copenhagen 23 April 2009 Annual Workshop of CRL - AR 1 Efsa s Role and Activities on AMR Scientific advices Analyses of data on AR submitted by MSs
More information10 Golden rules of Antibiotic Stewardship in ICU. Jeroen Schouten, MD PhD intensivist, Nijmegen (Neth) Istanbul, Oct 6th 2017
10 Golden rules of Antibiotic Stewardship in ICU Jeroen Schouten, MD PhD intensivist, Nijmegen (Neth) Istanbul, Oct 6th 2017 10 golden rules of Antibiotic Stewardship in the ICU ID, Pharma & Micro advice
More informationBugs, Drugs, and No More Shoulder Shrugs: The Role for Antimicrobial Stewardship in Long-term Care
Bugs, Drugs, and No More Shoulder Shrugs: The Role for Antimicrobial Stewardship in Long-term Care Molly Curran, PharmD, BCPS Clinical Assistant Professor The University of Texas College of Pharmacy Clinical
More informationAntimicrobial Stewardship in the Outpatient Setting. ELAINE LADD, PHARMD, ABAAHP, FAARFM OCTOBER 28th, 2016
Antimicrobial Stewardship in the Outpatient Setting ELAINE LADD, PHARMD, ABAAHP, FAARFM OCTOBER 28th, 2016 Abbreviations AMS - Antimicrobial Stewardship Program OP - Outpatient OPS - Outpatient Setting
More informationTo view an archived recording of this presentation please click the following link:
To view an archived recording of this presentation please click the following link: http://pho.adobeconnect.com/p3n7qn7y5kg/ Please scroll down this file to view a copy of the slides from the session.
More informationAntimicrobial Stewardship in the Hospital Setting
GUIDE TO INFECTION CONTROL IN THE HOSPITAL CHAPTER 12 Antimicrobial Stewardship in the Hospital Setting Authors Dan Markley, DO, MPH, Amy L. Pakyz, PharmD, PhD, Michael Stevens, MD, MPH Chapter Editor
More informationImpact of Antimicrobial Stewardship Program
Impact of Antimicrobial Stewardship Program Ripal Joshi, Pharm.D. AAHIVP Tampa General Hospital January 28, 2016 Objectives Provide an overview on antimicrobial stewardship programs (ASP) Describe the
More informationChallenges and opportunities for rapidly advancing reporting and improving inpatient antibiotic use in the U.S.
Challenges and opportunities for rapidly advancing reporting and improving inpatient antibiotic use in the U.S. Overview of benchmarking Antibiotic Use Scott Fridkin, MD, Senior Advisor for Antimicrobial
More informationAntimicrobial resistance and antimicrobial consumption in Europe
Antimicrobial resistance and antimicrobial consumption in Europe Dominique L. Monnet, on behalf of ECDC Antimicrobial Resistance and Healthcare-Associated Infections (ARHAI) Programme Vilnius, 28 November
More informationPromoting Handwashing Behavior: The Effect of Mass Media and Community Level Interventions in Peru
WATER AND SANITATION PROGRAM: Research Brief Global Scaling Up Handwashing Project Promoting Handwashing Behavior: The Effect of Mass Media and Community Level Interventions in Peru September 2012 Key
More informationEpidemiology and Economics of Antibiotic Resistance
Epidemiology and Economics of Antibiotic Resistance Eili Y. Klein February 17, 2016 Health Watch USA Meeting I. The burden of antibiotic resistance is a growing global threat, but hard numbers are lacking
More information